ID
41693
Description
The primary objective of this study was to demonstrate bioequivalence between eltrombopag oral film-coated tablets manufactured at Research and Development (R&D) and Commercial sites. The subject participants each went through two dosing periods (Period 1 and Period 2), during each of which they received a single dose of eltrombopag. The dosing periods were separated by a washout of at least 10 days. For each period, subjects had to perform a visit on the day before and one on the day of the administration of the drug. Furthermore, the protocol-defined visits included a screening visit and a follow-up visit. Study ID: 105122 Clinical Study ID: 105122 Study Title: Phase I Bioequivalence Study for SB 497115 GR Phase II and Phase III Tablets Sponsor: GlaxoSmithKline Phase: phase 1 Study Recruitment Status: Completed Generic Name: Eltrombopag Study Indication: Thrombocytopenia This form has to be filled out at the Follow-Up Visit.
Keywords
Versions (1)
- 12/18/20 12/18/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 18, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Eltrombopag Thrombocytopenia, Clinical Study ID: 105122
Study Conclusion and Pregnancy Information
- StudyEvent: ODM
Description
Study Conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008976
Description
date and time of subject completion or withdrawal
Data type
datetime
Alias
- UMLS CUI [1,1]
- C2348577
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [2,1]
- C2348577
- UMLS CUI [2,2]
- C0040223
- UMLS CUI [3,1]
- C1710677
- UMLS CUI [3,2]
- C0011008
- UMLS CUI [4,1]
- C1710677
- UMLS CUI [4,2]
- C0040223
Description
subject withdrawn from study
Data type
text
Alias
- UMLS CUI [1]
- C0422727
Description
subject withdrawn from study; primary reason
Data type
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1549995
Description
other reason for withdrawal, specification
Data type
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1549995
- UMLS CUI [1,3]
- C2348235
Description
Data owner should check the box when data cleaning is complete
Data type
text
Alias
- UMLS CUI [1,1]
- C1516308
- UMLS CUI [1,2]
- C1519316
Description
office use 1
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0442603
- UMLS CUI [1,2]
- C1524063
Description
office use 2
Data type
text
Alias
- UMLS CUI [1,1]
- C0442603
- UMLS CUI [1,2]
- C1524063
Description
Pregnancy information
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
Description
if yes, complete the paper Pregnancy Notification form
Data type
boolean
Alias
- UMLS CUI [1]
- C3828490
Description
If Yes, complete the paper Pregnancy Notification form
Data type
text
Alias
- UMLS CUI [1,1]
- C3828490
- UMLS CUI [1,2]
- C0919624
Similar models
Study Conclusion and Pregnancy Information
- StudyEvent: ODM
C0011008 (UMLS CUI [1,2])
C2348577 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C1710677 (UMLS CUI [3,1])
C0011008 (UMLS CUI [3,2])
C1710677 (UMLS CUI [4,1])
C0040223 (UMLS CUI [4,2])
C1549995 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C1519316 (UMLS CUI [1,2])
C1524063 (UMLS CUI [1,2])
C0919624 (UMLS CUI [1,2])